Systemic Markers of Interferon-γ–Mediated Immune Activation and Long-Term Prognosis in Patients With Stable Coronary Artery Disease
Author(s) -
Eva Ringdal Pedersen,
Øivind Midttun,
Per Magne Ueland,
Hall Schartum-Hansen,
Reinhard Seifert,
Jannicke Igland,
Jan Erik Nordrehaug,
Marta Ebbing,
G.F.T. Svingen,
Øyvind Bleie,
R J ten Berge,
Ottar Nygård
Publication year - 2010
Publication title -
arteriosclerosis thrombosis and vascular biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.007
H-Index - 270
eISSN - 1524-4636
pISSN - 1079-5642
DOI - 10.1161/atvbaha.110.219329
Subject(s) - neopterin , medicine , kynurenine , hazard ratio , unstable angina , coronary artery disease , stable angina , cardiology , inflammation , interferon gamma , proportional hazards model , gastroenterology , myocardial infarction , tryptophan , confidence interval , cytokine , biochemistry , chemistry , amino acid
Interferon γ (IFN-γ) is centrally involved in atherosclerosis-related inflammation, but its activity cannot be reliably assessed by systemic measurements. In activated macrophages, IFN-γ stimulates production of neopterin and conversion of tryptophan to kynurenine. We evaluated the relationships of plasma neopterin and plasma kynurenine:tryptophan ratio (KTR) to long-term prognosis in patients with stable angina pectoris and angiographically verified significant coronary artery disease.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom